Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

IRB

Showing results (481-490 of 778) with videos related to

Pageof 78
Sort By:
IRB|November 1, 1993
The Danish Brain Collection and its important potentials for future researchPovl Riis
IRB|July 1, 1995
DNA banking and informed consent -- part 1Robert F Weir, Jay R Horton
IRB|July 1, 1995
Clinical trials committees: how long is the protocol review and approval process in Spain? A prospective studyRafael Ortega, Rafael Dal-Ré
IRB|May 1, 1995
The case of two devices: disclosure to subjects following Phase IV ("post-marketing") researchJames R Anderson, Andrew Jameton, Paul J Reitemeier, et al.
IRB|May 1, 1996
The NIH inclusion guidelines: challenges for the futureKaren H Rothenberg, Eugene G Hayunga, Joyce E Rudick, et al.
IRB|January 1, 1997
Collaborative research involving human subjects: a survey of researchers using international single project assurancesAlison Wichman, Janet Smith, Deloris Mills, et al.
IRB|October 20, 2001
Some overlooked aspects of consent form readabilityMark Hochhauser
IRB|October 20, 2001
OPRR and FDA propose revised expedited review categoriesHelen McGough
IRB|October 1, 1982
Extra credit for research subjectsJeffrey M Cohen
IRB|October 20, 2001
Subject selection for clinical trials
Pageof 78

Showing results (481-490 of 778) with videos related to

Sort By:
Pageof 78
IRB|November 1, 1993
The Danish Brain Collection and its important potentials for future researchPovl Riis
IRB|July 1, 1995
DNA banking and informed consent -- part 1Robert F Weir, Jay R Horton
IRB|July 1, 1995
Clinical trials committees: how long is the protocol review and approval process in Spain? A prospective studyRafael Ortega, Rafael Dal-Ré
IRB|May 1, 1995
The case of two devices: disclosure to subjects following Phase IV ("post-marketing") researchJames R Anderson, Andrew Jameton, Paul J Reitemeier, et al.
IRB|May 1, 1996
The NIH inclusion guidelines: challenges for the futureKaren H Rothenberg, Eugene G Hayunga, Joyce E Rudick, et al.
IRB|January 1, 1997
Collaborative research involving human subjects: a survey of researchers using international single project assurancesAlison Wichman, Janet Smith, Deloris Mills, et al.
IRB|October 20, 2001
Some overlooked aspects of consent form readabilityMark Hochhauser
IRB|October 20, 2001
OPRR and FDA propose revised expedited review categoriesHelen McGough
IRB|October 1, 1982
Extra credit for research subjectsJeffrey M Cohen
IRB|October 20, 2001
Subject selection for clinical trials
Pageof 78